NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Novartis Venture Funds’

19 May 2014

Sorbent Therapeutics secures $6.5m

medical monitor Biopharmaceutical startup Sorbent Therapeutics, which is focused on developing therapies for cardiovascular and renal diseases, has closed a $6.5m tranche in its $15m Series D funding round.

30 April 2014

Infectious disease tester Atlas picks up £16.9m venture capital backing

virus2_sq UK-based infectious disease testing company Atlas Genetics has raised £16.9m in Series B funding from a string of venture capital firms.

23 April 2014

OrbiMed leads $22m round for Aerpio Therapeutics

biotech_lrg Biopharmaceutical startup Aerpio Therapeutics has secured $22m in a round led by venture capital firm OrbiMed.

15 May 2013

Apple Tree and Novartis back Tokai’s $35m Series E

pharmaceutical 12_sq Cancer-focused biotech firm Tokai Pharmaceuticals has wrapped up a $35m Series E round, which was supported by existing investors Apple Tree Partners and Novartis Venture Funds.

31 October 2012

Novo, Novartis lead $16m Series A for Thesan Pharmaceuticals

Thesan Pharmaceuticals has closed a $16m Series A round, co-led by corporate investment group Novo Ventures and life sciences-focused Novartis Venture Funds.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014